Explore more topics
SEC Form 4 research

Kymera Therapeutics, Inc. insider transactions

Inspect Kymera Therapeutics, Inc.'s public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001815442
Reporting owners
48
Officers and directors
18
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Read one actual disclosure before using it

Show the table · 1 row, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-10-012026-10-01Mainolfi NelloS262$116.12Not reported

First displayed source row from Recent insider disclosures. The full bounded history and coverage notes remain below.

The displayed observation date is 2026-10-01 and its public availability date is 2026-10-01. Subtracting those calendar dates gives 0 days of disclosure lag. Historical public research can use the record from the availability date, rather than backdating knowledge to the observation date. The calendar-day difference does not assert an intraday publication time.

This row is code S: a sale. A purchase-following rule excludes this sale even if the reported dollar amount is large.

Open the linked original receipts to verify the row, then inspect a second record before drawing a pattern. This public filing observation supplies source evidence, not a completed copy-trading return.

Recent insider disclosures

Inspect all 11 displayed rows: Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Scroll sideways to compare all columns. Select a heading to sort.

2026-10-012026-10-01Mainolfi NelloS262$116.12Not reported
2026-10-012026-10-01Mainolfi NelloS8,230$115.4Not reported
2026-10-012026-10-01Mainolfi NelloS7,601$114.43Not reported
2026-10-012026-10-01Mainolfi NelloS4,876$113.24Not reported
2026-10-012026-10-01Mainolfi NelloS5,506$112.42Not reported
2026-10-012026-10-01Mainolfi NelloS3,525$111.44Not reported
2026-09-052026-09-04Adams BrianS2,137$117.57Not reported
2026-09-052026-09-04Adams BrianS3,025$116.81Not reported
2026-09-052026-09-04Adams BrianS1,209$115.55Not reported
2026-07-282026-07-27Rooney TerenceA38,000$0Not reported
2026-07-282026-07-27Rooney TerenceA76,000$0Not reported

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Inspect all 30 displayed rows: Officers and directors in the directory

Scroll sideways to compare all columns. Select a heading to sort.

BVF GP HOLDINGS LLC0001803809304
BVF I GP LLC0001803805304
BVF II GP LLC0001803806304
Biotechnology Value Trading Fund OS LP0001660683554
BVF Partners OS Ltd.0001660684554
Jacobs Bruce N.000182107441
Ridloff Elena000177251823
Horobin Joanna00015609595
667, L.P.00015511392,118
Adams Brian000163699468
Albers Jeffrey W.0001638474162
Baker Bros. Advisors (GP) LLC00015805752,197
BAKER BROS. ADVISORS LP00012635082,370
Baker Brothers Life Sciences LP00013633642,127
BAKER FELIX00010879404,174
BAKER JULIAN00010879394,416
BIOTECHNOLOGY VALUE FUND II LP00011024441,471
BIOTECHNOLOGY VALUE FUND L P00009189231,480
Booth Bruce0001451612273
BVF INC/IL00010568071,482
BVF PARTNERS L P/IL00010559471,482
Caughey Elaine00018686682
Chadwick Jeremy G000138840634
Chesworth Richard00018211885
Chiniara Ellen00013987644
Esposito Pamela000174442537
Gollob Jared000182119846
Goodman Noah00020600759
LAMPERT MARK N00012338401,002
Mainolfi Nello000182118978

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.